4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001209191-21-029073
Chief Financial Officer acquired 28,718 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Finley John David · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-04-27 | Grant or award : show line 1 in the form | +2,396 | 2,396 | D |
| 2021-04-27 | Grant or award : show line 2 in the form | +26,322 | 26,322 | I |
Table II: Derivative
19 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-04-27 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +10,418 | 10,418 | D |
| 2021-04-27 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +9,516 | 9,516 | D |
| 2021-04-27 | Grant or award : show line 5 in the form Stock Option (Right to Buy) | +52,068 | 52,068 | D |
| 2021-04-27 | Grant or award : show line 6 in the form Stock Option (Right to Buy) | +14,708 | 14,708 | D |
| 2021-04-27 | Grant or award : show line 7 in the form Stock Option (Right to Buy) | +5,662 | 5,662 | D |
| 2021-04-27 | Grant or award : show line 8 in the form Stock Option (Right to Buy) | +19,033 | 19,033 | D |
| 2021-04-27 | Grant or award : show line 9 in the form Stock Option (Right to Buy) | +9,702 | 9,702 | D |
| 2021-04-27 | Grant or award : show line 10 in the form Stock Option (Right to Buy) | +7,952 | 7,952 | D |
Loading xslF345X03/doc4.xml…